Advertisement
Australia markets close in 5 hours 39 minutes
  • ALL ORDS

    8,401.30
    -73.00 (-0.86%)
     
  • ASX 200

    8,133.10
    -72.10 (-0.88%)
     
  • AUD/USD

    0.6850
    +0.0007 (+0.10%)
     
  • OIL

    73.81
    +0.10 (+0.14%)
     
  • GOLD

    2,676.20
    -3.00 (-0.11%)
     
  • Bitcoin AUD

    88,703.20
    -6.42 (-0.01%)
     
  • XRP AUD

    0.76
    -0.01 (-1.22%)
     
  • AUD/EUR

    0.6204
    +0.0007 (+0.11%)
     
  • AUD/NZD

    1.1017
    +0.0009 (+0.09%)
     
  • NZX 50

    12,533.25
    -39.41 (-0.31%)
     
  • NASDAQ

    19,793.34
    -9.24 (-0.05%)
     
  • FTSE

    8,282.52
    -8.34 (-0.10%)
     
  • Dow Jones

    42,011.59
    -184.93 (-0.44%)
     
  • DAX

    19,015.41
    -149.34 (-0.78%)
     
  • Hang Seng

    22,113.51
    -330.22 (-1.47%)
     
  • NIKKEI 225

    38,639.03
    +86.97 (+0.23%)
     

Is Universal Biosensors (ASX:UBI) In A Good Position To Invest In Growth?

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.

Given this risk, we thought we'd take a look at whether Universal Biosensors (ASX:UBI) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

Check out our latest analysis for Universal Biosensors

Does Universal Biosensors Have A Long Cash Runway?

A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at September 2023, Universal Biosensors had cash of AU$16m and such minimal debt that we can ignore it for the purposes of this analysis. In the last year, its cash burn was AU$11m. Therefore, from September 2023 it had roughly 17 months of cash runway. That's not too bad, but it's fair to say the end of the cash runway is in sight, unless cash burn reduces drastically. The image below shows how its cash balance has been changing over the last few years.

debt-equity-history-analysis
debt-equity-history-analysis

How Well Is Universal Biosensors Growing?

It was fairly positive to see that Universal Biosensors reduced its cash burn by 27% during the last year. Revenue also improved during the period, increasing by 5.7%. On balance, we'd say the company is improving over time. Of course, we've only taken a quick look at the stock's growth metrics, here. You can take a look at how Universal Biosensors has developed its business over time by checking this visualization of its revenue and earnings history.

How Easily Can Universal Biosensors Raise Cash?

Universal Biosensors seems to be in a fairly good position, in terms of cash burn, but we still think it's worthwhile considering how easily it could raise more money if it wanted to. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Many companies end up issuing new shares to fund future growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Universal Biosensors has a market capitalisation of AU$55m and burnt through AU$11m last year, which is 21% of the company's market value. That's not insignificant, and if the company had to sell enough shares to fund another year's growth at the current share price, you'd likely witness fairly costly dilution.

Is Universal Biosensors' Cash Burn A Worry?

Even though its cash burn relative to its market cap makes us a little nervous, we are compelled to mention that we thought Universal Biosensors' cash burn reduction was relatively promising. We don't think its cash burn is particularly problematic, but after considering the range of factors in this article, we do think shareholders should be monitoring how it changes over time. Separately, we looked at different risks affecting the company and spotted 4 warning signs for Universal Biosensors (of which 1 doesn't sit too well with us!) you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.